Endocrine Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others), By Diagnostic Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others), By End User (Hospitals, Diagnostic Laboratories and others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis, and Forecast till 2030

Endocrine testing market accounted for US$ 181.47 billion in 2020 and is estimated to be US$ 869.6 billion by 2030 and is anticipated to register a CAGR of 8.9%.

The endocrine system comprises hormones and group of glands that carry hormones directly to the circulatory system. Thyroid gland and the adrenal glands are major glands in humans, which operate various body activities such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Imbalance in hormone concentration leads to certain disorder, which can be used as marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as thyroid stimulating hormone, insulin, human chorionic gonadotropin, follicle stimulating hormones, progesterone, cortisol, prolactin, testosterone, and other hormones.

High prevalence of endocrine disorders

Endocrine testing measures endocrine hormone concentration to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other hormonal disorder. Moreover, high prevalence of endocrine disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to drive growth of endocrine testing market over the forecast period. However, high cost of advanced endocrine testing technologies in emerging economies is restraining growth of the market. Furthermore, lack of awareness regarding diagnostics tests among populations is hindering market growth.

Endocrine testing market is segmented on the basis of test, diagnostic technology, end user, and region. On the basis of type, endocrine testing market is segmented into thyroid, insulin, follicle stimulating hormone, luteinizing, hormone, estradiol, testosterone, progesterone, human chorionic gonadotropin, prolactin, cortisol DHEA-S, and others. On the basis of by diagnostic technology, endocrine testing market is segmented into immunoassay, tandem mass spectroscopy, monoclonal and polyclonal antibody, sensor technologies, clinical chemistry, and others. On the basis of end user endocrine testing market is segmented into hospitals, diagnostic laboratories and others. On the basis of region, endocrine testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Regional Insights:

On region the endocrine testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to have a considerable share due to factors such as well-established healthcare infrastructure, high prevalence of obesity, developments in diagnostic technologies, and new product launches. The market is expected to rise due to a decrease in physical activity and an increase in the incidence of thyroid problems.

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the endocrine testing market report based on Test, Diagnostic Technology, End User and Region.

Endocrine Testing Market, By Region:

• • • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Key players operating in endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, and Quest Diagnostics.

• Abbott Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Thermo Fisher Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Beckman Coulter, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Siemens Healthineers
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• bioMérieux SA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Agilent Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• BioRad Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• AB Sciex
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F-Hoffmann La Roche AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Quest Diagnostics
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies